Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $20.8000 (1.96%) ($20.1300 - $21.1900) on Wed. Nov. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.26% (three month average) | RSI | 80 | Latest Price | $20.8000(1.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 5.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 22.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -2.13% in a week (0% probabilities). VIXM(-32%) VXX(-25%) UNG(-11%) UUP(-8%) TLT(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.13% (StdDev 4.26%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $19.38(7.33%) | 10 Day Moving Average | $17.15(21.28%) | 20 Day Moving Average | $15.51(34.11%) | To recent high | 0% | To recent low | 74.5% | Market Cap | $1.546b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |